Monovalent and multivalent OspA mRNA-LNP vaccines elicit functional antibodies and protect against Borrelia burgdorferi in mice.
Saved in:
| Title: | Monovalent and multivalent OspA mRNA-LNP vaccines elicit functional antibodies and protect against Borrelia burgdorferi in mice. |
|---|---|
| Authors: | Finn MB; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA., Willsey G; Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY, USA., Piazza CL; Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY, USA., Clendenen L; Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, USA., Shrestha M; Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, USA., You SS; Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, USA., Ma L; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA., Dhingra Y; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA., Laciak AR; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA., Uggowitzer KA; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA., Obiero JM; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA., Freeman-Gallant G; Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY, USA., Natarajan H; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA., Green S; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA., Pirayesh E; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA., Lai YT; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA., Himansu S; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA., Carfi A; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA., Hu LT; Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, USA., Mantis N; Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY, USA., Plante O; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA., Dold C; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA. Christina.Dold@modernatx.com. |
| Source: | NPJ vaccines [NPJ Vaccines] 2026 May 05. Date of Electronic Publication: 2026 May 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42086599 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Monovalent and multivalent OspA mRNA-LNP vaccines elicit functional antibodies and protect against Borrelia burgdorferi in mice. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Finn+MB%22">Finn MB</searchLink>; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Willsey+G%22">Willsey G</searchLink>; Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY, USA.<br /><searchLink fieldCode="AU" term="%22Piazza+CL%22">Piazza CL</searchLink>; Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY, USA.<br /><searchLink fieldCode="AU" term="%22Clendenen+L%22">Clendenen L</searchLink>; Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shrestha+M%22">Shrestha M</searchLink>; Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22You+SS%22">You SS</searchLink>; Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ma+L%22">Ma L</searchLink>; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Dhingra+Y%22">Dhingra Y</searchLink>; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Laciak+AR%22">Laciak AR</searchLink>; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Uggowitzer+KA%22">Uggowitzer KA</searchLink>; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Obiero+JM%22">Obiero JM</searchLink>; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Freeman-Gallant+G%22">Freeman-Gallant G</searchLink>; Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY, USA.<br /><searchLink fieldCode="AU" term="%22Natarajan+H%22">Natarajan H</searchLink>; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Green+S%22">Green S</searchLink>; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Pirayesh+E%22">Pirayesh E</searchLink>; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lai+YT%22">Lai YT</searchLink>; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Himansu+S%22">Himansu S</searchLink>; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Carfi+A%22">Carfi A</searchLink>; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hu+LT%22">Hu LT</searchLink>; Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Mantis+N%22">Mantis N</searchLink>; Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY, USA.<br /><searchLink fieldCode="AU" term="%22Plante+O%22">Plante O</searchLink>; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Dold+C%22">Dold C</searchLink>; Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA. Christina.Dold@modernatx.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101699863%22">NPJ vaccines</searchLink> [NPJ Vaccines] 2026 May 05. <i>Date of Electronic Publication: </i>2026 May 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature+in+partnership+with+the+Sealy+Center+for+Vaccine+Development%22">Springer Nature in partnership with the Sealy Center for Vaccine Development </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101699863 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-0105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220590105%22">20590105 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Vaccines |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42086599 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41541-026-01451-7 Languages: – Code: eng Text: English Titles: – TitleFull: Monovalent and multivalent OspA mRNA-LNP vaccines elicit functional antibodies and protect against Borrelia burgdorferi in mice. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Finn MB – PersonEntity: Name: NameFull: Willsey G – PersonEntity: Name: NameFull: Piazza CL – PersonEntity: Name: NameFull: Clendenen L – PersonEntity: Name: NameFull: Shrestha M – PersonEntity: Name: NameFull: You SS – PersonEntity: Name: NameFull: Ma L – PersonEntity: Name: NameFull: Dhingra Y – PersonEntity: Name: NameFull: Laciak AR – PersonEntity: Name: NameFull: Uggowitzer KA – PersonEntity: Name: NameFull: Obiero JM – PersonEntity: Name: NameFull: Freeman-Gallant G – PersonEntity: Name: NameFull: Natarajan H – PersonEntity: Name: NameFull: Green S – PersonEntity: Name: NameFull: Pirayesh E – PersonEntity: Name: NameFull: Lai YT – PersonEntity: Name: NameFull: Himansu S – PersonEntity: Name: NameFull: Carfi A – PersonEntity: Name: NameFull: Hu LT – PersonEntity: Name: NameFull: Mantis N – PersonEntity: Name: NameFull: Plante O – PersonEntity: Name: NameFull: Dold C IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 05 Text: 2026 May 05 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2059-0105 Titles: – TitleFull: NPJ vaccines Type: main |
| ResultId | 1 |